Percutaneous endovascular management of Angio-Seal related vascular occlusion.
Angio‐Seal
atherectomy
femoral artery occlusion
percutaneous endovascular intervention
vascular closure device
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
27 Oct 2024
27 Oct 2024
Historique:
revised:
29
09
2024
received:
09
09
2024
accepted:
09
10
2024
medline:
28
10
2024
pubmed:
28
10
2024
entrez:
28
10
2024
Statut:
aheadofprint
Résumé
The use of vascular closure devices (VCDs) to achieve quick and safe hemostasis after femoral arterial access is widely accepted. Major complications include bleeding and occlusion of the femoral artery due to device failure, which often necessitates vascular intervention. This manuscript details our peripheral percutaneous endovascular interventional (PEI) approach for the management of femoral artery occlusion resulting from Angio-Seal (Terumo, Somerset, New Jersey, USA) VCD deployment. Consecutive patients who developed occlusive complications after Angio-Seal deployment underwent PEI to overcome specific complications. Patients' clinical and procedural characteristics, along with their short- and long-term follow-up data, were analyzed. The study cohort included 40 patients who experienced Angio-Seal occlusive complications between July 2013 and September 2023. The mean age of the patients was 74 ± 10 years and 55% were female. All the patients were treated with PEI, with an overall procedural success rate of 100%. The primary approach for PEI was directional atherectomy, which was used in 35 cases (88%), followed by balloon, while a cutting balloon was used in 5 patients (13%). Stenting served as the definitive therapy in only 7 patients (18%). No procedural complications or conversions to surgery were observed. During a median follow-up of 244 (IQR = 100-707) days, none of the patients required re-intervention related to Angio-Seal occlusion and salvage intervention. In the management of Angi-Seal VCD-related femoral artery occlusion, the adjunctive use of directional atherectomy followed by balloon angioplasty was effective and safe, allowing re-establishment of flow with excellent long-term outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
The use of vascular closure devices (VCDs) to achieve quick and safe hemostasis after femoral arterial access is widely accepted. Major complications include bleeding and occlusion of the femoral artery due to device failure, which often necessitates vascular intervention. This manuscript details our peripheral percutaneous endovascular interventional (PEI) approach for the management of femoral artery occlusion resulting from Angio-Seal (Terumo, Somerset, New Jersey, USA) VCD deployment.
METHODS
METHODS
Consecutive patients who developed occlusive complications after Angio-Seal deployment underwent PEI to overcome specific complications. Patients' clinical and procedural characteristics, along with their short- and long-term follow-up data, were analyzed.
RESULTS
RESULTS
The study cohort included 40 patients who experienced Angio-Seal occlusive complications between July 2013 and September 2023. The mean age of the patients was 74 ± 10 years and 55% were female. All the patients were treated with PEI, with an overall procedural success rate of 100%. The primary approach for PEI was directional atherectomy, which was used in 35 cases (88%), followed by balloon, while a cutting balloon was used in 5 patients (13%). Stenting served as the definitive therapy in only 7 patients (18%). No procedural complications or conversions to surgery were observed. During a median follow-up of 244 (IQR = 100-707) days, none of the patients required re-intervention related to Angio-Seal occlusion and salvage intervention.
CONCLUSION
CONCLUSIONS
In the management of Angi-Seal VCD-related femoral artery occlusion, the adjunctive use of directional atherectomy followed by balloon angioplasty was effective and safe, allowing re-establishment of flow with excellent long-term outcomes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Unoki T, Konami Y, Nakayama T, et al. Efficacy and safety of post‐closure technique using perclose ProGlide/ProStyle device for large‐bore mechanical circulatory support access sites. Cardiovasc Revascularization Med. 2024;62:60–65. doi:10.1016/j.carrev.2023.12.016
Nuis RJ, Wood D, Kroon H, et al. Frequency, impact, and predictors of access complications with plug‐based large‐bore arteriotomy closure ‐ A patient‐level meta‐analysis. Cardiovasc Revascularization Med. 2022;34:69–74. doi:10.1016/j.carrev.2021.02.017
Pang N, Gao J, Zhang B, et al. Vascular closure devices versus manual compression in cardiac interventional procedures: systematic review and meta‐analysis. Cardiovasc Ther. 2022;2022:8569188. doi:10.1155/2022/8569188
Koreny M, Riedmüller E, Nikfardjam M, Siostrzonek P, Müllner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta‐analysis. JAMA. 2004;291(3):350–357. doi:10.1001/jama.291.3.350
Biancari F, D'Andrea V, Marco CD, Savino G, Tiozzo V, Catania A. Meta‐analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J. 2010;159(4):518–531. doi:10.1016/j.ahj.2009.12.027
Bhogal S, Waksman R. Vascular closure: the ABC's. Curr Cardiol Rep. 2022;24(4):355–364. doi:10.1007/s11886-022-01654-z
Chatzigeorgiadis P, Hellwig K, Almasi‐Sperling V, Meyer A, Lang W, Rother U. Major vascular complications after transfemoral arterial closure system implantation: a single‐center study. Int Angiol. 2020;39(2):139–144. doi:10.23736/S0392-9590.19.04253-6
Nash JE, Evans DG. The angio‐seal hemostatic puncture closure device. concept and experimental results. Herz. 1999;24(8):597–606. doi:10.1007/BF03044483
Martin JL, Pratsos A, Magargee E, et al. A randomized trial comparing compression, perclose proglide and angio‐seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial. Catheter Cardiovasc Interv. 2008;71(1):1–5. doi:10.1002/ccd.21333
Hvelplund A, Jeger R, Osterwalder R, et al. The angio‐seal™ femoral closure device allows immediate ambulation after coronary angiography and percutaneous coronary intervention. EuroIntervention. 2011;7(2):234–241. doi:10.4244/EIJV7I2A38
Sarin SN, Shah RK, Chun A, et al. Use of the 8‐F angio‐seal vascular closure device in large‐caliber arteriotomies. J Endovasc Ther. 2012;19(4):497–500. doi:10.1583/12-3881.1
Siani A, Accrocca F, Gabrielli R, et al. Management of acute lower limb ischemia associated with the angio‐seal arterial puncture closing device. Interact Cardiovasc Thorac Surg. 2011;12(3):400–403. doi:10.1510/icvts.2010.252486
Abando A, Hood D, Weaver F, Katz S. The use of the angioseal device for femoral artery closure. J Vasc Surg. 2004;40(2):287–290. doi:10.1016/j.jvs.2004.05.007
Sharma R, Vamanan K, Gupta K. Treatment of angio‐seal® vascular closure device‐induced acute femoral artery occlusion with SilverHawk® directional atherectomy. Cureus. 2016 Dec 2;8(12):e910. doi:10.7759/cureus.910 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5208580/
Jiao A, Goldman D, Hussain J, et al. Aspiration thrombectomy‐assisted endovascular retrieval of an embolized angio‐seal device causing claudication. Ann Vasc Surg. 2019;60:476.e7–476.e11. doi:10.1016/j.avsg.2019.02.047
Shariq M, Premnath KPB, Saleh AT, Coker J. Complications with the use of angio‐seal vascular closure device and their management. J Clin Imaging Sci. 2023;13:26. doi:10.25259/JCIS_68_2023
Sprouse LR, Botta DM, Hamilton IN. The management of peripheral vascular complications associated with the use of percutaneous suture‐mediated closure devices. J Vasc Surg. 2001;33(4):688–693. doi:10.1067/mva.2001.112324
Biancari F, Ylönen K, Mosorin M, Lepojärvi M, Juvonen T. Lower limb ischemic complications after the use of arterial puncture closure devices. Eur J Vasc Endovasc Surg. 2006;32(5):504–505. doi:10.1016/j.ejvs.2006.04.023
Van Den Broek T, Liqui Lung PF, Suttorp MJ, Eefting FD, Schipper ME, Vink A. Vascular occlusion as a late complication of the angio‐seal closure device. A review of literature. Minerva Cardioangiol. 2007;55(6):815–819.
Nguyen BN, Amdur RL, Abugideiri M, Rahbar R, Neville RF, Sidawy AN. Postoperative complications after common femoral endarterectomy. J Vasc Surg. 2015;61(6):1489–1494.e1. doi:10.1016/j.jvs.2015.01.024
Dong H, Peng M, Jiang X, et al. Endovascular therapy for angio‐sealTM ‐related acute limb ischemia: perioperative and long‐term results. Catheter Cardiovasc Interv. 2017;89(S1):609–615. doi:10.1002/ccd.26936
Jiao A, Goldman D, Hussain J, et al. Aspiration thrombectomy‐assisted endovascular retrieval of an embolized angio‐seal device causing claudication. Ann Vasc Surg. 2019;60:476.e7–476.e11. doi:10.1016/j.avsg.2019.02.047
Merdler I, Bernardo NL, Ben‐Dor I, Waksman R. Cutting balloon for femoral arterial and Venus obstructions due to suture‐based closure devices: case series. Catheter Cardiovasc Interv. 2023;101(7):1235‐1238. doi:10.1002/ccd.30668